Fate Therapeutics
Earnings Surprise
Analysts estimated FATE earnings of $-0.30 per share this quarter (Q3). FATE's actual earnings were $-0.27 per share.
FATE EPS surprise of 9.06%Analysts estimated FATE earnings of $-0.35 per share this quarter (Q2). FATE's actual earnings were $-0.29 per share.
FATE EPS surprise of 16.98%Analysts estimated FATE earnings of $-0.39 per share this quarter (Q1). FATE's actual earnings were $-0.32 per share.
FATE EPS surprise of 18.10%Analysts estimated FATE earnings of $-0.44 per share this quarter (Q3). FATE's actual earnings were $-0.40 per share.
FATE EPS surprise of 9.28%Analysts estimated FATE earnings of $-0.48 per share this quarter (Q2). FATE's actual earnings were $-0.33 per share.
FATE EPS surprise of 31.92%Analysts estimated FATE earnings of $-0.50 per share this quarter (Q1). FATE's actual earnings were $-0.47 per share.
FATE EPS surprise of 5.72%Analysts estimated FATE earnings of $-0.53 per share this quarter (Q4). FATE's actual earnings were $-0.45 per share.
FATE EPS surprise of -15.59%